LEO PHARMA INC
1
Recalls
0
Units Recalled
0
Injuries
0
Deaths
1 category · 2026-03-04 to 2026-03-04
| Date | Source | Product | Brand | Severity | Units |
|---|---|---|---|---|---|
| 2026-03-04 | FDA Drug | FDA Recall: Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPL | LEO PHARMA INC | Class II | N/A |